We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02233439
Recruitment Status : Unknown
Verified September 2014 by Antonella Cromi, Università degli Studi dell'Insubria.
Recruitment status was:  Not yet recruiting
First Posted : September 8, 2014
Last Update Posted : September 8, 2014
Milte Italia SpA
Information provided by (Responsible Party):
Antonella Cromi, Università degli Studi dell'Insubria

Brief Summary:
The purpose of this study is to assess the effectiveness of a commercially available product containing a combination of Silybum marianum and Galega officinalis to support continuation or augmentation of breast milk production.

Condition or disease Intervention/treatment Phase
Breastfeeding Dietary Supplement: Herbal galactagogue Dietary Supplement: Placebo Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 210 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy of Herbal Galactogogues: a Double-blinded, Placebo-controlled Randomized Trial.
Study Start Date : September 2014
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : March 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breastfeeding

Arm Intervention/treatment
Placebo Comparator: Placebo
a placebo identical in appearance to the galactagogue product
Dietary Supplement: Placebo
No Intervention: No treatment
Usual care and breastfeeding support
Experimental: Herbal galactagogue
A commercially available product containing a combination of Silybum marianum 400 mg and Galega officinalis 150 mg, once a day for 6 weeks
Dietary Supplement: Herbal galactagogue
Other Name: Piùlatte® Plus (MILTE ITALIA SpA)

Primary Outcome Measures :
  1. Percentage of mothers who exclusively breastfeed their child [ Time Frame: At 6 weeks postpartum ]

Secondary Outcome Measures :
  1. Rate of breastfeeding (either exclusively or as a supplement to formula feeding ) [ Time Frame: at 6 weeks and 3 months ]
  2. Volume (mL) and frequency (times a day) of formula [ Time Frame: 6 weeks postpartum ]
  3. weight gain experienced by the newborns [ Time Frame: 6 weeks postpartum ]
  4. serum prolactin level [ Time Frame: at baseline and 6 weeks after treatment ]
  5. Rate of maternal allergic reactions and gastrointestinal side effects [ Time Frame: 6 weeks postpartum ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • singleton, term delivery
  • >2.5 kg newborn weight
  • lactation-deficiency

Exclusion Criteria:

  • Neonatal Intensive Care Unit admission
  • use of galactagogue drugs
  • allergy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02233439

Layout table for location contacts
Contact: Antonella Cromi, MD antonella.cromi@uninsubria.it

Layout table for location information
Azienda Ospedaliero-Universitaria Ospedale di Circolo e Fondazione Macchi, Presidio F. Del Ponte
Varese, Italy, 21100
Principal Investigator: Antonella Cromi, MD         
Sponsors and Collaborators
Università degli Studi dell'Insubria
Milte Italia SpA
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Antonella Cromi, Associate professor, Università degli Studi dell'Insubria
ClinicalTrials.gov Identifier: NCT02233439    
Other Study ID Numbers: IRB 54/2013
First Posted: September 8, 2014    Key Record Dates
Last Update Posted: September 8, 2014
Last Verified: September 2014
Keywords provided by Antonella Cromi, Università degli Studi dell'Insubria:
Silybum marianum
Galega officinalis
Additional relevant MeSH terms:
Layout table for MeSH terms
Physiological Effects of Drugs